Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness

被引：31

作者：

Johnson, LN ^{[1
]}

Han, JY

Moskowitz, SM

Burns, JL

Qin, X

Englund, JA

机构：

[1] Univ Washington, Sch Med, Div Infect Dis Immunol & Rheumatol, Seattle, WA 98195 USA

[2] Univ Washington, Sch Med, Div Pulm Med, Seattle, WA 98195 USA

[3] Univ Washington, Childrens Hosp, Dept Labs & Pathol, Seattle, WA 98195 USA

[4] Univ Washington, Reg Med Ctr, Seattle, WA 98195 USA

[5] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2004年 / 23卷 / 09期

关键词：

Pandoraea; bacteremia; cystic fibrosis;

D O I：

10.1097/01.inf.0000136857.74561.3c

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Pandoraea is a recently classified genus primarily isolated from the sputum of cystic fibrosis patients, but its pathogenic potential is unknown. We describe a case of Pandoraea bacteremia in a 16-year-old cystic fibrosis patient associated with clinical disease, suggesting that this organism should be considered a true pathogen in susceptible patients.

引用

页码：881 / 882

页数：2

共 11 条

[1] Description of Pandoraea gen. nov with Pandoraea apista sp nov., Pandoraea pulmonicola sp nov., Pandoraea pnomenusa sp nov., Pandoraea sputorum sp nov and Pandoraea norimbergensis comb. nov. [J].

Coenye, T ;

Falsen, E ;

Hoste, B ;

Ohlén, M ;

Goris, J ;

Govan, JRW ;

Gillis, M ;

Vandamme, P .

INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2000, 50 :887-899

[2] Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays [J].

Coenye, T ;

Liu, LX ;

Vandamme, P ;

LiPuma, JJ .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (12) :4452-4455

[3] Assignment of CDC weak oxidizer group 2 (WO-2) to the genus Pandoraea and characterization of three new Pandoraea genomospecies [J].

Daneshvar, MI ;

Hollis, DG ;

Steigerwalt, AG ;

Whitney, AM ;

Spangler, L ;

Douglas, MP ;

Jordan, JG ;

MacGregor, JP ;

Hill, BC ;

Tenover, FC ;

Brenner, DJ ;

Weyant, RS .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (05) :1819-1826

[4]

Dawson KG, 1999, PEDIATR INFECT DIS J, V18, P816, DOI [10.1097/00006454-199909000-00014, 10.1097/00006454-199902000-00015]

[5] PSEUDOMONAS CEPACIA INFECTION IN CYSTIC-FIBROSIS - AN EMERGING PROBLEM [J].

ISLES, A ;

MACLUSKY, I ;

COREY, M ;

GOLD, R ;

PROBER, C ;

FLEMING, P ;

LEVISON, H .

JOURNAL OF PEDIATRICS, 1984, 104 (02) :206-210

[6] Epidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients [J].

Jorgensen, IM ;

Johansen, HK ;

Frederiksen, B ;

Pressler, T ;

Hansen, A ;

Vandamme, P ;

Hoiby, N ;

Koch, C .

PEDIATRIC PULMONOLOGY, 2003, 36 (05) :439-446

[7] Nonradioactive method to study genetic profiles of natural bacterial communities by PCR-single-strand-conformation polymorphism [J].

Lee, DH ;

Zo, YG ;

Kim, SJ .

APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1996, 62 (09) :3112-3120

[8] Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis:: Virulent transmissible strains of genomovar III can replace Burkholderia multivorans [J].

Mahenthiralingam, E ;

Vandamme, P ;

Campbell, ME ;

Henry, DA ;

Gravelle, AM ;

Wong, LTK ;

Davidson, AGF ;

Wilcox, PG ;

Nakielna, B ;

Speert, DP .

CLINICAL INFECTIOUS DISEASES, 2001, 33 (09) :1469-1475

[9] Pandoraea apista isolated from a patient with cystic fibrosis:: problems associated with laboratory identification [J].

Moore, JE ;

Reid, A ;

Millar, BC ;

Xu, JR ;

McCaughan, J ;

Goldsmith, CE ;

Collins, J ;

Murphy, PG ;

Elborn, JS .

BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2002, 59 (03) :164-166

[10] Use of amplified ribosomal DNA restriction analysis for identification of Ralstonia and Pandoraea species:: Interest in determination of the respiratory bacterial flora in patients with cystic fibrosis [J].

Segonds, C ;

Paute, S ;

Chabanon, G .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (07) :3415-3418

← 1 2 →